Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2016	Oct. 03, 2015
Operating Activities
Net loss	$ (26,508)	$ (48,664)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	29,448	30,016
Deferred income taxes	1,193	926
Non-cash portion of restructuring costs	0	4,035
Provision for allowance for doubtful accounts	1,671	1,137
Amortization of deferred financing costs and premium on senior notes	2,823	2,696
Gain on sale or disposal of assets	(941)	(45)
Stock based compensation expense	189	129
Changes in operating assets and liabilities:
Accounts receivable	(35,516)	(42,005)
Inventories	(15,072)	(15,974)
Accounts payable and accrued liabilities	34,818	59,732
Income taxes receivable / payable	5,686	506
Other assets and liabilities	(214)	(1,031)
Net cash used in operating activities	(2,423)	(8,542)
Investing Activities
Capital expenditures	(6,718)	(14,628)
Proceeds from the sale of assets	1,474	140
Net cash used in investing activities	(5,244)	(14,488)
Financing Activities
Borrowings under ABL facilities	132,789	135,731
Payments under ABL facilities	(145,649)	(110,653)
Proceeds from promissory note	27,500	0
Financing fees	(3,203)	0
Net cash provided by financing activities	11,437	25,078
Effect of exchange rate changes on cash and cash equivalents	14	(70)
Net increase in cash and cash equivalents	3,784	1,978
Cash and cash equivalents at beginning of period	9,394	5,963
Cash and cash equivalents at end of period	13,178	7,941
Cash paid during the period for:
Interest	41,685	40,947
Income taxes	126	3,525
Capital expenditures incurred but not yet paid	$ 511	$ 614